Rapid learning for precision oncology (Q38180318)

30 August 2017

Rapid learning for precision oncology (English)

1 reference

30 August 2017

Jeff Shrager

1

1 reference

PubMed ID

24445514

30 August 2017

Jay M Tenenbaum

series ordinal

2

1 reference

PubMed ID

24445514

30 August 2017

language of work or name

English

0 references

publication date

21 January 2014

1 reference

Nature Reviews Clinical Oncology

30 August 2017

1 reference

30 August 2017

11

1 reference

30 August 2017

2

1 reference

30 August 2017

109-118

1 reference

A small-cell lung cancer genome with complex signatures of tobacco exposure

30 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

A comprehensive catalogue of somatic mutations from a human cancer genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

Can we deconstruct cancer, one patient at a time?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

Genomics-driven oncology: framework for an emerging paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

Trastuzumab and beyond: sequencing cancer genomes and predicting molecular networks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

Reverse-engineering the genetic circuitry of a cancer cell with predicted intervention in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

Signatures of mutational processes in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

Reverse-engineering human regulatory networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

The transcriptional network for mesenchymal transformation of brain tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

Towards patient-based cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

Leveraging models of cell regulation and GWAS data in integrative network-based association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

Diseases as network perturbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

Clinical implications of the cancer genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

Revising regulatory networks: from expression data to linear causal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

Genetic network inference: from co-expression clustering to reverse engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

Reverse engineering of regulatory networks in human B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

Computational and experimental approaches for modeling gene regulatory networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

Reverse engineering of TLX oncogenic transcriptional networks identifies RUNX1 as tumor suppressor in T-ALL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

Genome sequencing identifies a basis for everolimus sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

Biomedicine. Rare cancer successes spawn 'exceptional' research efforts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

Comparative effectiveness research, genomics-enabled personalized medicine, and rapid learning health care: a common bond

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

Targeted next-generation sequencing of advanced prostate cancer identifies potential therapeutic targets and disease heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

Building a personalized medicine infrastructure at a major cancer center

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

A rapid-learning health system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

Rapid-learning system for cancer care

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

Implementing personalized medicine in a cancer center

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

Cancer genome sequencing--an interim analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

The origin and evolution of mutations in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

A landscape of driver mutations in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

Cancer genes and the pathways they control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

Git can facilitate greater reproducibility and increased transparency in science

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

A point-of-care clinical trial comparing insulin administered using a sliding scale versus a weight-based regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

The BATTLE trial: personalizing therapy for lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

Adaptive clinical trials in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

Implementation of the Department of Veterans Affairs' first point-of-care clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

Adaptive clinical trial designs for simultaneous testing of matched diagnostics and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

The clinically-integrated randomized trial: proposed novel method for conducting large trials at low cost

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

ASCO's approach to a learning health care system in oncology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

Envisioning Watson as a rapid-learning system for oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

A melanoma molecular disease model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

A novel classification of lung cancer into molecular subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

A multi-site feasibility study for personalized medicine in canines with osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

Soccer science and the Bayes community: exploring the cognitive implications of modern scientific communication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

Opportunities and challenges in the development of experimental drug combinations for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

'Basket studies' will hold intricate data for cancer drug approvals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

Off-label use of anti-cancer drugs between clinical practice and research: the Italian experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

Market and patient access to new oncology products in Europe: a current, multidisciplinary perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

Reconstructing targetable pathways in lung cancer by integrating diverse omics data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

JAK1 truncating mutations in gynecologic cancer define new role of cancer-associated protein tyrosine kinase aberrations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

Whole-genome analysis informs breast cancer response to aromatase inhibition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

Adaptive designs in clinical drug development--an Executive Summary of the PhRMA Working Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

Rethinking clinical trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.244

Emerging therapies in melanoma.

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24445514

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Guiding revision of regulatory models with expression data

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24445514

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Perturbation of interaction networks for application to cancer therapy.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24445514

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRCLINONC.2013.244

1 reference

30 August 2017

1 reference

PubMed ID

24445514